TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ELAN

Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.10$ +1.7% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ELAN
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
58.3% 54.2% 59.4% 57.8% 54.4% 61.9% 56.4% 55.3% 56.1% 57.0% 56.5%
41.7% 45.8% 40.6% 42.2% 45.6% 38.1% 43.6% 44.7% 43.9% 43.0% 43.5%
10.0% 9.1% 8.7% 8.0% 8.8% 10.0% 7.7% 7.3% 7.4% 7.7% 7.8%
31.5% 26.9% 27.0% 24.0% 24.8% 30.4% 24.3% 24.1% 24.3% 24.3% 30.3%
41.5% 36.1% 35.7% 32.0% 33.5% 40.4% 37.2% 36.0% 36.5% 37.4% 38.1%
0.2% 9.7% 4.9% 10.2% 12.0% -2.3% 6.4% 8.7% 7.4% 5.7% 5.3%
0.0% 0.0% 0.0% 1.0% 2.6% 4.8% 5.5% 5.8% 6.3% 7.6% 4.7%
-8.9% -0.8% -8.1% 3.7% 2.5% -20.5% -12.0% -1.6% -27.1% 11.0% -4.8%
-1.7% 0.9% 2.7% 0.9% 0.3% -3.4% -1.8% 0.1% 0.8% 3.4% 0.2%
-7.2% -1.6% -10.8% 2.8% 2.2% -17.1% -10.1% -1.8% -27.9% 7.6% -4.9%
-0.8% 8.0% 3.0% 14.3% 15.4% 0.0% 8.6% 19.6% -5.1% 33.5% 14.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?